miR‐122‐3p has been shown to prevent metabolic diseases by inhibiting Fas, HmgCoA, and Srebp and also has implications in steroid hormone biosynthesis (Alisi et al., 2009; Tsai et al., 2012). This evidence concerns the gene FAS and Other metabolic disease.